A legacy of hope
Thank you for taking the first step to creating a better future for all those affected by ME/CFS, by considering…
A gut biomarker for ME/CFS?
The microbiome refers to the collection of around 100 trillion microorganisms, including bacteria, that live on or inside the human…
“World-first study” – ME Research UK-funded project acclaimed in Australian media
The results from Dr Leighton Barnden and colleagues at Griffith University Queensland, Australia ME Research UK-funded study have been covered…
Sarah Annesley announced as Tracey Banivanua Mar Fellow for 2023
We were delighted with the news that Dr Sarah Annesley was recently announced as one of the Tracey Banivanua Mar…
Parliamentary Questions on Fibromyalgia
Fibromyalgia is a chronic condition with similar overlaping symptoms and challenges as those faced by people with ME/CFS. In fact,…
Brainstem volume changes
Dr Leighton Barnden and colleagues at Griffith University in Queensland, Australia have just published the first results from their ME…
Scottish Good Practice Statement on ME/CFS – February 2023 Update
It was announced on 28th February 2023 that the Scottish Good Practice Statement on ME/CFS has undergone a partial update…
Fundraising Focus – February 2023
The team at ME Research UK is very grateful for all the support which the charity receives from its active…
Irish ME/CFS Association award to ME Research UK
ME Research UK is delighted to have been awarded €9000 by The Irish ME/CFS Association in its latest round of…
